Protalix BioTherapeutics, Inc.: Optionsscheine CALL PUT | A2PWSL | US74365A3095

Markt geschlossen - NYSE 21:00:00 30.10.2026			Perf. 5 T	Veränd. 1. Jan.
2.590 ^USD	-0.77%		+1.57%	+43.89%

16.09.	Protalix BioTherapeutics, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 01:05 PM
12.08.	Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026

Optionsscheine Protalix BioTherapeutics, Inc.